Publicacions en col·laboració amb investigadors/es de Centro Nacional de Investigaciones Cardiovasculares Carlos III (74)

2024

  1. Age-Related Retinal Layer Thickness Changes Measured by OCT in APPNL-F/NL-F Mice: Implications for Alzheimer’s Disease

    International Journal of Molecular Sciences, Vol. 25, Núm. 15

  2. Circadian Effects on Vascular Immunopathologies

    Circulation Research, Vol. 134, Núm. 6, pp. 791-809

  3. From Alzheimer's disease to vascular dementia: Different roads leading to cognitive decline

    British Journal of Pharmacology

  4. Myeloid cells in vascular dementia and Alzheimer's disease: Possible therapeutic targets?

    British Journal of Pharmacology, Vol. 181, Núm. 6, pp. 777-798

  5. N-acetylcysteine during critical neurodevelopmental periods prevents behavioral and neurochemical deficits in the Poly I:C rat model of schizophrenia

    Translational Psychiatry, Vol. 14, Núm. 1

  6. Oral anticoagulants: A plausible new treatment for Alzheimer's disease?

    British Journal of Pharmacology, Vol. 181, Núm. 6, pp. 760-776

  7. Remodeling p38 signaling in muscle controls locomotor activity via IL-15

    Science advances, Vol. 10, Núm. 33, pp. eadn5993

  8. Retinal Vascular and Structural Changes in the Murine Alzheimer’s APPNL-F/NL-F Model from 6 to 20 Months

    Biomolecules, Vol. 14, Núm. 7

  9. THC improves behavioural schizophrenia-like deficits that CBD fails to overcome: a comprehensive multilevel approach using the Poly I:C maternal immune activation

    Psychiatry Research, Vol. 331

  10. The mitochondrial Na+/Ca2+ exchanger NCLX is implied in the activation of hypoxia-inducible factors

    Redox Biology, Vol. 77

  11. The role of gut microbiota in cerebrovascular disease and related dementia

    British Journal of Pharmacology, Vol. 181, Núm. 6, pp. 816-839

2023

  1. Beneficial effect of TLR4 blockade by a specific aptamer antagonist after acute myocardial infarction

    Biomedicine and Pharmacotherapy, Vol. 158

  2. Correction to: Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective (Cell & Bioscience, (2023), 13, 1, (44), 10.1186/s13578-023-00986-9)

    Cell and Bioscience

  3. Defective hippocampal neurogenesis underlies cognitive impairment by carotid stenosis-induced cerebral hypoperfusion in mice

    Frontiers in Cellular Neuroscience, Vol. 17

  4. Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer

    Nature Communications, Vol. 14, Núm. 1

  5. Ipsilesional Hippocampal GABA Is Elevated and Correlates With Cognitive Impairment and Maladaptive Neurogenesis After Cortical Stroke in Mice

    Stroke, Vol. 54, Núm. 10, pp. 2652-2665

  6. Longitudinal interplay between subclinical atherosclerosis, cardiovascular risk factors, and cerebral glucose metabolism in midlife: results from the PESA prospective cohort study

    The Lancet Healthy Longevity, Vol. 4, Núm. 9, pp. e487-e498

  7. Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective

    Cell and Bioscience, Vol. 13, Núm. 1

  8. Neuroimaging Revealed Long-Lasting Glucose Metabolism Changes to Morphine Withdrawal in Rats Pretreated with the Cannabinoid Agonist CP-55,940 during Periadolescence

    European Neuropsychopharmacology, Vol. 69, pp. 60-76

  9. Neutrophil β1 adrenoceptor blockade blunts stroke-associated neuroinflammation

    British Journal of Pharmacology, Vol. 180, Núm. 4, pp. 459-478